Efficacy of apremilast in hyperkeratotic hand and foot dermatitis: results from a randomized observer-blinded comparative study.

Kriti Bhat Suman PatraAbhishek BhardwajSaurabh SinghAnil BudaniaAnupama BainsSuman Saurabh

Published in: International journal of dermatology (2024)

Adding apremilast to topical corticosteroid leads to better patient and physician-perceived improvement and reduces the number of flares in hyperkeratotic hand eczema.

Keyphrases

atopic dermatitis
emergency department
primary care
social support
case report
depressive symptoms
mental health
study protocol
randomized controlled trial
clinical trial
placebo controlled